Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 545 results for "sun pharmaceutical industries"

Sebi smells rat in Sun Pharma-Ranbaxy deal
Business Today India

Luthra, Amarchand, Crawford, Shearman, Davis Polk advise on Su...

Indian drug maker, Sun Pharmaceutical Industries shall be paying about $4 billion in an all-stock deal to acquire generic drug maker Ranbaxy Laboratories. Daiichi Sankyo, the majority shareholder in Ranbaxy will acquire a 9 per cent stake in Sun ... Bar & Bench, 21 hours ago
Sun Pharma Acquires Ranbaxy Laboratories Process Worldwide, 5 days ago
[x]  

108 images for sun pharmaceutical industries

Business Today India, 2 weeks ago
The Hindu, 2 weeks ago
The Hindu, 2 weeks ago
South Florida Sun-Sentinel, 1 week ago
KFGO News, 1 week ago
Irish Times, 2 weeks ago
Rediff.com, 1 week ago
Rediff.com, 1 week ago
Rediff.com, 1 week ago
Rediff.com, 1 week ago

BEARING RANBAXY BURDEN

The takeover of Daiichi Sankyo owned Ranbaxy Labs by Sun Pharmaceuticals for $4 billion including a $800 million liability early this month surprised quite a few in the Indian pharmaceutical industry. There was hardly any indication of such a move ...
 PharmaBiz5 hours ago

Glenmark Pharma drops after losing appeal to invalidate Abbott's TARKA patent

Capital Market April 22, 2014 Last Updated at 13:14 IST Key benchmark indices trimmed intraday gains in early afternoon trade. The barometer index, the S&P BSESensex, was up 18.08 points or 0.08%, off close to 70 points from the day's high and up ...
 Business Standard India22 hours ago
Deccan Chronicle

Ranbaxy's journey as a...

Ranbaxy Laboratories will cease to exist as a company after completion of the USD 4 billion merger with Sun Pharmaceuticals, although its brands will be kept alive in over 100 markets. "The Ranbaxy entity will be merged into Sun Pharma and Sun ...
 Siasat Daily1 day ago Sun to merge Ranbaxy, to keep brands alive  Deccan Chronicle2 days ago Ranbaxy will cease to exist after merger with Sun Pharma  Space View Times2 days ago Ranbaxy's journey as a company to end after merger with Sun Pharma  NDTV Profit3 days ago
[x]  

Sun Pharmaceutical Industries to convene EGM

This page uses frames, but your browser doesn't
 Capital Market1 day ago Sun Pharma's court convened meeting of shareholders on May 05, 2014  Money Control2 days ago Sun Pharma gains after strong Q3 outcome  Business Standard2 months ago Sun Pharmaceutical Industries: Q3 results on Feb 13, 2014  Money Control2 months ago
Reuters India

In defence of the defensives: Why IT, pharma stocks are not pariahs

(Any opinions expressed here are those of the author and not of Thomson Reuters) Expectation that the ongoing general election will throw up a stable government has spurred a return to risk in domestic equities. The consequent rally has meant ...
 Reuters India1 day ago
Reuters India

Ranbaxy Drugs to be Rebranded as Sun Pharma to Help U.S. Reputation

According to Reuter's sources, Sun Pharmaceutical Industries will begin phasing out sales of generic drugs branded as Ranbaxy Laboratories in the United States, following Sun's $3.2 billion aquisition of Ranbaxy in early April. The rebranding of ...
 Pharmaceutical Manufacturing Magazine5 days ago Sun plans gradual phase-out of ranbaxy-branded drugs in us  4 Traders1 week ago Sun To Phase Out Ranbaxy Drugs In US  Businessworld India1 week ago Sun plans phasing out of Ranbaxy-brand drugs in US  Reuters India1 week ago
[x]  
Finance 24

Investors back Sun Pharma's Ranbaxy move (AFP)

On the surface, Sun Pharma's $US3.2 billion ($A3.42 billion) purchase of Indian generics rival Ranbaxy, which is in deep trouble with US regulators over safety lapses, may not look like a great deal. But Sun Pharmaceutical Industries' shares ...
 West Australian1 week ago Sun Pharma is able to revive Ranbaxy: investors  China Post1 week ago 'Sun Pharma can nurse Ranbaxy to health'  Finance 241 week ago Investors back Sun's Ranbaxy deal as well-calculated risky acquisition  Oman Tribune1 week ago
[x]  

Sun Pharma continues to outglow its peers

Related to : Sun Pharmaceuticals Industries Ltd Sun Pharmaceuticals Industries Ltd BSE 17 Apr 14 | 12:00 AM 624.30 9.7 (1.58%) NSE 17 Apr 14 | 12:00 AM 625.05 11.2 (1.82%) Performance is built into the DNA of Sun Pharma. The ...
 Smart Investor4 days ago
India Today

Sun rises on Ranbaxy

M.G. Arun New Delhi,April 18, 2014| UPDATED15:41 IST Dilip Shanghvi, CEO, Sun Pharmaceutical Industries Ltd. It isn't easy to cast Dilip Shanghvi, 58, Chief Executive Officer of Sun Pharmaceutical Industries Ltd into a classic CEO mould. He ...
 India Today4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sun pharmaceutical industries
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less